Minerva Neurosciences NERV
NASDAQ NERV
$2.45 -0.04 (-1.41%)
As of: Nov 11, 2026 · 12:07 PM EST

Minerva Neurosciences (NERV) Long-Term Investments (2015 - 2017)

Updated

Minerva Neurosciences' Long-Term Investments came in at $5.02 million for Q4 2017, down 51.5% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) Long-Term Investments (2015 - 2017) Analysis & Trends

Going back to Q2 2015, Minerva Neurosciences' Long-Term Investments data covers 4 quarters.

  • The Q4 2017 figure represents the lowest quarterly Long-Term Investments since Q3 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Minerva Neurosciences 124.09 Mn -188.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 5.02 Mn
Sep 30, 2017 10.36 Mn
Sep 30, 2015 1.41 Mn
Jun 30, 2015 9.44 Mn
API Access

Minerva Neurosciences Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=NERV&period=max&api_key=YOUR_API_KEY